Pancreatic Cancer Updates

Course Overview

Course Outline

1. Introduction 
2. Case Study 
3. Statistical Evidence/Epidemiology 
4. Etiology/Pathophysiology 
5. Diagnostic and Screening Tools 
6. Medication Management 
7. Common Misconceptions 
8. Upcoming Research 
9. Conclusion 

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Pancreatic Cancer Updates​. It will take the average learner 60 minutes to complete and awards contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Discuss the etiology and pathophysiology of Pancreatic Ductal Adenocarcinoma (PDAC). 
2. Describe the impact of both modifiable and non-modifiable risk factors in PDAC. 
3. Discuss the latest advancements in immunotherapy, targeted therapies, genetic research, and the role of innovative diagnostic tools like circulating tumor DNA (ctDNA). 
4. Explain the importance of early detection, the effectiveness of a multidisciplinary treatment approach, and the necessity of integrating comprehensive treatment strategies and public education in combating PDAC. 

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.